DK1157998T3 - Heterocykliske forbindelser, mellemprodukter derfor og elastaseinhibitorer - Google Patents

Heterocykliske forbindelser, mellemprodukter derfor og elastaseinhibitorer

Info

Publication number
DK1157998T3
DK1157998T3 DK00905282T DK00905282T DK1157998T3 DK 1157998 T3 DK1157998 T3 DK 1157998T3 DK 00905282 T DK00905282 T DK 00905282T DK 00905282 T DK00905282 T DK 00905282T DK 1157998 T3 DK1157998 T3 DK 1157998T3
Authority
DK
Denmark
Prior art keywords
group
different
same
intermediates
heterocyclic compounds
Prior art date
Application number
DK00905282T
Other languages
Danish (da)
English (en)
Inventor
Fuminori Sato
Yasunao Inoue
Tomoki Omodani
Ryotaro Shiratake
Seiji Honda
Masanobu Komiya
Tadashi Takemura
Original Assignee
Dainippon Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dainippon Pharmaceutical Co filed Critical Dainippon Pharmaceutical Co
Application granted granted Critical
Publication of DK1157998T3 publication Critical patent/DK1157998T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0202—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-X-X-C(=0)-, X being an optionally substituted carbon atom or a heteroatom, e.g. beta-amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/022—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -X-C(=O)-(C)n-N-C-C(=O)-Y-; X and Y being heteroatoms; n being 1 or 2
    • C07K5/0222—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -X-C(=O)-(C)n-N-C-C(=O)-Y-; X and Y being heteroatoms; n being 1 or 2 with the first amino acid being heterocyclic, e.g. Pro, Trp
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0802—Tripeptides with the first amino acid being neutral
    • C07K5/0804—Tripeptides with the first amino acid being neutral and aliphatic
    • C07K5/0806—Tripeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atoms, i.e. Gly, Ala
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0821—Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
    • C07K5/1008—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atoms, i.e. Gly, Ala
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Pyridine Compounds (AREA)
DK00905282T 1999-03-03 2000-02-23 Heterocykliske forbindelser, mellemprodukter derfor og elastaseinhibitorer DK1157998T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP11056052A JP2000256396A (ja) 1999-03-03 1999-03-03 複素環式化合物およびその中間体ならびにエラスターゼ阻害剤
PCT/JP2000/001022 WO2000052032A1 (fr) 1999-03-03 2000-02-23 Composes heterocycliques, leurs intermediaires, et inhibiteurs d'elastase

Publications (1)

Publication Number Publication Date
DK1157998T3 true DK1157998T3 (da) 2004-06-14

Family

ID=13016323

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00905282T DK1157998T3 (da) 1999-03-03 2000-02-23 Heterocykliske forbindelser, mellemprodukter derfor og elastaseinhibitorer

Country Status (23)

Country Link
US (1) US6835714B1 (tr)
EP (1) EP1157998B1 (tr)
JP (1) JP2000256396A (tr)
KR (1) KR100622709B1 (tr)
CN (1) CN1183156C (tr)
AT (1) ATE259376T1 (tr)
AU (1) AU758739B2 (tr)
CA (1) CA2362911A1 (tr)
DE (1) DE60008218T2 (tr)
DK (1) DK1157998T3 (tr)
ES (1) ES2215608T3 (tr)
HK (1) HK1044955B (tr)
HU (1) HUP0200608A3 (tr)
IL (2) IL144813A0 (tr)
MX (1) MXPA01008836A (tr)
NZ (1) NZ513594A (tr)
PL (1) PL199136B1 (tr)
PT (1) PT1157998E (tr)
RU (1) RU2222539C2 (tr)
TR (1) TR200102540T2 (tr)
TW (1) TW534905B (tr)
WO (1) WO2000052032A1 (tr)
ZA (1) ZA200106514B (tr)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002002546A1 (fr) * 2000-06-30 2002-01-10 Seikagaku Corporation Amides d'acide carboxylique, azides et amino-alcools et procedes de preparation de $g(a)-ceto amides a l'aide de ces derniers
RU2355700C9 (ru) 2000-07-21 2010-03-20 Шеринг Корпорейшн Новые пептиды как ингибиторы ns3-серинпротеазы вируса гепатита с
US7244721B2 (en) 2000-07-21 2007-07-17 Schering Corporation Peptides as NS3-serine protease inhibitors of hepatitis C virus
AR029851A1 (es) 2000-07-21 2003-07-16 Dendreon Corp Nuevos peptidos como inhibidores de ns3-serina proteasa del virus de hepatitis c
BR0112666A (pt) 2000-07-21 2003-06-10 Schering Corp Peptìdeos como inibidores de ns3-serina protease de vìrus da hepatite c
GB0021315D0 (en) * 2000-08-30 2000-10-18 Dainippon Pharmaceutical Co Heterocyclic compounds and intermediates thereof
EP1323419A1 (en) * 2000-09-29 2003-07-02 Ono Pharmaceutical Co., Ltd. Airway mucus secretion inhibitors
PL371539A1 (en) 2002-02-05 2005-06-27 Dainippon Pharmaceutical Co, Ltd. Heterocyclic compounds having elastase-inhibiting activity and intermediates thereof
CA2557307A1 (en) * 2004-02-27 2005-09-22 Schering Corporation 3,4-(cyclopentyl)-fused proline compounds as inhibitors of hepatitis c virus ns3 serine protease
JP2009538327A (ja) 2006-05-23 2009-11-05 アイアールエム・リミテッド・ライアビリティ・カンパニー チャネル活性化プロテアーゼ阻害剤である化合物および組成物
DE602007013387D1 (de) * 2006-05-23 2011-05-05 Irm Llc Verbindungen und zusammensetzungen als kanalaktivierende protease-hemmer
WO2008032331A1 (en) * 2006-09-12 2008-03-20 Himalaya Global Holdings Ltd. Herbal composition for the prevention of wrinkles and skin disorders, methods of preparing the same and uses thereof
MX2009008518A (es) * 2007-02-09 2009-08-20 Irm Llc Compuestos y composiciones como inhibidores de la proteasa activadora de canal.
US20100239551A1 (en) * 2007-02-09 2010-09-23 Irm Llc Compounds and compositions as channel activating protease inhibitors
WO2012127885A1 (ja) 2011-03-18 2012-09-27 小野薬品工業株式会社 テトラヒドロカルボリン誘導体
CN104031014B (zh) * 2013-03-08 2016-05-11 华中师范大学 香豆素衍生物及其制备方法以及弹性蛋白酶活性检测方法和检测试剂盒
CN104165869B (zh) * 2013-05-17 2016-12-28 华中师范大学 一种检测蛋白水解酶活性的方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CS231228B1 (en) 1982-10-01 1984-10-15 Evzen Kasafirek Biologically effective tri and tetrapeptide alkylamide derivatives and their processing method
GB8600263D0 (en) 1985-01-22 1986-02-12 Ici America Inc Peptide derivatives
GB8809316D0 (en) 1987-05-11 1988-05-25 Ici America Inc Heterocyclic ketones
US5017610A (en) 1988-06-13 1991-05-21 Ono Pharmaceutical Co., Ltd. Derivatives of p-substituted phenyl ester of pivalic acid
US5565568A (en) * 1995-04-06 1996-10-15 Eli Lilly And Company 2-acylaminopropanamides as tachykinin receptor antagonists

Also Published As

Publication number Publication date
PL199136B1 (pl) 2008-08-29
EP1157998B1 (en) 2004-02-11
ZA200106514B (en) 2002-05-10
KR100622709B1 (ko) 2006-09-13
DE60008218D1 (de) 2004-03-18
KR20020002396A (ko) 2002-01-09
EP1157998A1 (en) 2001-11-28
TR200102540T2 (tr) 2002-01-21
EP1157998A4 (en) 2003-01-29
RU2222539C2 (ru) 2004-01-27
AU2690200A (en) 2000-09-21
HUP0200608A3 (en) 2002-09-30
HK1044955B (zh) 2005-07-08
PT1157998E (pt) 2004-06-30
IL144813A0 (en) 2002-06-30
CN1349542A (zh) 2002-05-15
AU758739B2 (en) 2003-03-27
JP2000256396A (ja) 2000-09-19
HUP0200608A2 (en) 2002-08-28
CA2362911A1 (en) 2000-09-08
US6835714B1 (en) 2004-12-28
DE60008218T2 (de) 2004-12-09
IL144813A (en) 2006-12-10
ES2215608T3 (es) 2004-10-16
MXPA01008836A (es) 2002-05-14
ATE259376T1 (de) 2004-02-15
HK1044955A1 (en) 2002-11-08
NZ513594A (en) 2003-04-29
TW534905B (en) 2003-06-01
WO2000052032A1 (fr) 2000-09-08
CN1183156C (zh) 2005-01-05

Similar Documents

Publication Publication Date Title
DK1157998T3 (da) Heterocykliske forbindelser, mellemprodukter derfor og elastaseinhibitorer
DE69431974D1 (de) Benzamid-Derivate und ihre Verwendung als Vasopressin-Antagonisten
ATE253545T1 (de) Biarylessigsäure-derivate und ihre verwendung als cox-2 inhibitoren
EA200500910A1 (ru) Бифенильные производные и их применение в качестве фунгицидов
NO953305L (no) Antranilsyrederivat
KR20050085991A (en) Compounds exhibiting thrombopoietin receptor agonism
ATE297203T1 (de) Antithrombotische mitteln
AU7517400A (en) N-substituted 4-aminopteridines, synthesis and use thereof as pharmaceutical agent
DE69231445T2 (de) Triazole enthaltende antifungizide mittel
DE69839753D1 (de) 2-(Arylphenyl)amino-imidazolin-Derivate
ATE276257T1 (de) Pyrazinonderivate
NO20002589D0 (no) Bifenylamidinderivater
DE69910121D1 (de) Piperidone als Tachykinin-Hemmer
DE60045821D1 (de) Derivate von aromatische heterocyclen enthaltende integraseinhibitoren
DK1053679T3 (da) Herbicide sammensætninger
DK1370539T3 (da) HIV-inhiberende N-aminoimidazolderivater
TH102375A (th) อนุพันธ์พิแรโซล และการใช้ของมัน
EA200200462A1 (ru) Производные 2-арилхинолина, их получение и терапевтическое применение
TH102375B (th) อนุพันธ์พิแรโซล และการใช้ของมัน
ATE262522T1 (de) Benzimidazolverbindungen